Brief Report: Tepotinib as a Treatment Option in MET Exon 14 Skipping-Positive Lung Cancers—Investigating Discordance Between ArcherMET and the Oncomine Dx Target Test by Yoshihiro Miyashita, MD, Yosuke Hirotsu, PhD, Yuki Nagakubo, MS, Hiroaki Kobayashi, MD, Makoto Kawaguchi, MD, Koki Hata, MD, Ryota Saito, MD, Yumiko Kakizaki, MD, Toshiharu Tsutsui, PhD, Toshio Oyama, MD, Masao Omata, MD

Get full text

TP53 Loss of Heterozygosity Induces De Novo SCLC Formation in EGFR-Mutated Lung Adenocarcinoma: A Case Report by Kei Kunimasa, MD, PhD, Yosuke Hirotsu, PhD, Kenji Amemiya, MSH, Harumi Nakamura, MD, PhD, Kazumi Nishino, MD, PhD, Keiichiro Honma, MD, PhD, Jiro Okami, MD, PhD, Masao Omata, MD, PhD, Toru Kumagai, MD, PhD

Get full text

Urinary L-Type Fatty Acid-Binding Protein Predicts Oxygen Demand of COVID-19 in Initially Mild Cases by Daisuke Katagiri, MD, PhD, FASN, Yusuke Asai, PhD, Norio Ohmagari, MD, PhD, Masahiro Ishikane, MD, PhD, Sayaka Hikida, MD, PhD, Noriko Iwamoto, MD, PhD, Maki Nagashima, MT, Minami Suzuki, MD, PhD, Hideki Takano, MD, PhD, Jin Takasaki, MD, Masayuki Hojo, MD, PhD, Haruhito Sugiyama, MD, PhD, Katsushi Tokunaga, PhD, Yoshihiro Miyashita, MD, Masao Omata, MD, PhD, Keiichi Ohata, MS, Kevin P. Bliden, MBA, Udaya S. Tantry, PhD, Jeffrey R. Dahlen, PhD, Takeshi Sugaya, PhD, Paul A. Gurbel, MD, FACC, Eisei Noiri, MD, PhD, FASN

Get full text